Triamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retiniana
- A Salinas-Alamán
- A García-Layana
- LM Sádaba-Echarri
- A Belzunce-Manterola
ISSN: 0365-6691
Argitalpen urtea: 2005
Alea: 80
Zenbakia: 8
Orrialdeak: 463-466
Mota: Artikulua
Beste argitalpen batzuk: Archivos de la Sociedad Española de Oftalmologia
Laburpena
Clinical cases: Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose. The remaining one case suffered a relapse three months later. Therefore a second injection was performed in that case. Discussion: Several treatments have been suggested to manage macular edema in BRVO. Intravitreal triamcinolone may be a therapeutic option to increase visual acuity and decrease macular thickness in patients with macular edema secondary to BRVO.
Erreferentzia bibliografikoak
- Finkelstein, D. (1992). Ischemic macular edema: Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 110. 1427-1434
- (1984). Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 98. 271-282
- Firueroa, MS, Torres, R, Alvarez, MT. (2004). Comparative study fo vitrectomy with and without vein decompression for branch retinal vein occlusion: a pilot study. Eur J Ophthalmol. 14. 40-47
- Karacorlu, M, Ozdemir, H, Karacorlu, S. (2004). Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients. Retina. 24. 324-327
- Jonas, JB, Akkoyun, I, Kamppeter, B, Kreissig, I, Degenring, RF. (2004). Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 23. 1-7